Jens Radzimanowski
Director Antibody Therapeutics Lead Identification
Boehringer Ingelheim
Lyon, France
21 profile visitsSpeakerSponsor
My organisation
Boehringer Ingelheim Animal Health is a global leader in animal health, dedicated to preventing and treating diseases in animals. As part of the family‑owned Boehringer Ingelheim group, the company develops and provides vaccines, pharmaceuticals, and health solutions for pets, livestock, and horses, working closely with veterinarians, farmers, and animal owners worldwide to support animal well‑being and improve human–animal relationships.
Speaker sessions (1)
Wednesday, 20 May 2026
14:00 - 14:45
Masterclass 2: Illuminating Mechanism of Action in Veterinary Antibody R&D: From Biology to Functional Bioassays
Location:BMCC - 3rd Floor - Cat RoomTrack:Masterclass
This Masterclass will present a joint Promega– Boehringer Ingelheim session focused on illuminating mechanism-of-action (MoA) strategies in veterinary antibody research and development through the application of luminescent bioassays.
Sign-ups available from 1 Apr 2026, 00:00 to 20 May 2026, 14:45